1. Short title This Act may be cited as the Strengthening our Health Security Through Resilient Medical Supply Chains Annual Review Act of 2020 . 2. Report on security and resilience of the United States medical supply chains (a) In general Not later than one year after the date of the enactment of this Act, and annually thereafter, the Secretary of Homeland Security shall submit to the Committee on Homeland Security of the House of Representatives, and the Committee on Homeland Security and Government Affairs of the Senate a report on the security and resilience of the United States medical supply chains. Such a report shall contain a classified annex. The Secretary shall make publicly available (including by publication on the website of the Department of Homeland Security) the unclassified portion of the report. (b) Contents The report submitted under subsection (a) shall— (1) review the United States supply chains for medical devices, supplies, and drugs and the vulnerability of such supply chains to a global disruption, such as an instance of bioterrorism, a natural disaster, or a public health emergency; (2) assess the dependence of the United States on any medical devices, equipment, supplies, countermeasures, vaccines, and drugs produced or sourced outside the United States; and (3) identify the actions the Federal government has taken during the year covered by the report— (A) to promote the security and resilience of the United States medical supply chain; (B) to improve medical supply chain redundancy; (C) to encourage the domestic production of medical devices, equipment, supplies, countermeasures, vaccines, and drugs; and (D) to develop contingency plans for potential global disruptions